Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1,448 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $1,448 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $12,188 | $16,375 | $24,772 | $34,853 |
| G&A Expenses | $12,213 | $9,976 | $11,915 | $12,481 |
| SG&A Expenses | $12,213 | $9,976 | $11,915 | $12,481 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $8,279 | $1,322 | $0 | $181 |
| Operating Expenses | $32,680 | $27,673 | $36,687 | $47,334 |
| Operating Income | -$27,818 | -$27,673 | -$36,687 | -$46,067 |
| % Margin | – | – | – | -3,181.4% |
| Other Income/Exp. Net | -$1,860 | $125,764 | -$75,975 | -$10,448 |
| Pre-Tax Income | -$29,678 | $98,091 | -$112,662 | -$84,558 |
| Tax Expense | -$6,318 | $7 | $0 | -$10,448 |
| Net Income | -$23,360 | $98,084 | -$112,662 | -$84,558 |
| % Margin | – | – | – | -5,839.6% |
| EPS | -7.18 | 31.55 | -56.63 | -33.66 |
| % Growth | -122.8% | 155.7% | -68.2% | – |
| EPS Diluted | -7.18 | 31.55 | -56.63 | -33.66 |
| Weighted Avg Shares Out | 3,256 | 3,109 | 1,989 | 1,679 |
| Weighted Avg Shares Out Dil | 3,256 | 3,109 | 1,989 | 1,679 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $9 | $165 | $1,150 |
| Interest Expense | $204 | $7 | $3 | $0 |
| Depreciation & Amortization | $1,656 | $22 | $61 | $120 |
| EBITDA | -$27,818 | $98,120 | -$112,598 | -$56,395 |
| % Margin | – | – | – | -3,894.7% |